Acadia Healthcare Company, Inc. (ACHC)
USD 39.05
(-1.49%)
USD 39.05
(-1.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.51 Billion USD | -1.17% |
| 2022 | 1.52 Billion USD | -6.64% |
| 2021 | 1.63 Billion USD | -49.23% |
| 2020 | 3.22 Billion USD | -12.37% |
| 2019 | 3.68 Billion USD | 15.25% |
| 2018 | 3.19 Billion USD | -1.43% |
| 2017 | 3.23 Billion USD | -1.46% |
| 2016 | 3.28 Billion USD | 46.73% |
| 2015 | 2.24 Billion USD | 104.4% |
| 2014 | 1.09 Billion USD | 77.64% |
| 2013 | 617.13 Million USD | 30.39% |
| 2012 | 473.31 Million USD | 70.59% |
| 2011 | 277.45 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.97 Billion USD | -0.66% |
| 2024 Q1 | 1.98 Billion USD | 31.52% |
| 2024 Q3 | 1.87 Billion USD | 1.84% |
| 2023 Q3 | 1.5 Billion USD | -1.69% |
| 2023 FY | 1.51 Billion USD | -1.17% |
| 2023 Q1 | 1.56 Billion USD | 2.18% |
| 2023 Q4 | 1.51 Billion USD | 0.21% |
| 2023 Q2 | 1.53 Billion USD | -1.82% |
| 2022 FY | 1.52 Billion USD | -6.64% |
| 2022 Q4 | 1.52 Billion USD | -0.98% |
| 2022 Q3 | 1.54 Billion USD | -0.38% |
| 2022 Q2 | 1.54 Billion USD | -4.98% |
| 2022 Q1 | 1.63 Billion USD | -0.4% |
| 2021 Q2 | 1.56 Billion USD | -2.11% |
| 2021 FY | 1.63 Billion USD | -49.23% |
| 2021 Q1 | 1.59 Billion USD | -50.44% |
| 2021 Q3 | 1.54 Billion USD | -1.56% |
| 2021 Q4 | 1.63 Billion USD | 6.3% |
| 2020 FY | 3.22 Billion USD | -12.37% |
| 2020 Q1 | 3.64 Billion USD | -0.96% |
| 2020 Q3 | 3.66 Billion USD | 0.83% |
| 2020 Q4 | 3.22 Billion USD | -11.9% |
| 2020 Q2 | 3.63 Billion USD | -0.39% |
| 2019 Q3 | 3.68 Billion USD | -2.01% |
| 2019 FY | 3.68 Billion USD | 15.25% |
| 2019 Q1 | 3.79 Billion USD | 18.93% |
| 2019 Q2 | 3.76 Billion USD | -0.89% |
| 2019 Q4 | 3.68 Billion USD | -0.22% |
| 2018 Q2 | 3.22 Billion USD | -0.64% |
| 2018 FY | 3.19 Billion USD | -1.43% |
| 2018 Q3 | 3.21 Billion USD | -0.18% |
| 2018 Q1 | 3.24 Billion USD | 0.06% |
| 2018 Q4 | 3.19 Billion USD | -0.68% |
| 2017 Q2 | 3.27 Billion USD | -0.19% |
| 2017 Q1 | 3.28 Billion USD | -0.2% |
| 2017 Q4 | 3.23 Billion USD | -0.89% |
| 2017 FY | 3.23 Billion USD | -1.46% |
| 2017 Q3 | 3.26 Billion USD | -0.19% |
| 2016 Q3 | 3.66 Billion USD | 0.27% |
| 2016 Q1 | 3.56 Billion USD | 59.18% |
| 2016 FY | 3.28 Billion USD | 46.73% |
| 2016 Q4 | 3.28 Billion USD | -10.21% |
| 2016 Q2 | 3.65 Billion USD | 2.38% |
| 2015 Q1 | 2.05 Billion USD | 87.36% |
| 2015 Q4 | 2.24 Billion USD | 4.99% |
| 2015 Q3 | 2.13 Billion USD | 9.27% |
| 2015 Q2 | 1.95 Billion USD | -4.91% |
| 2015 FY | 2.24 Billion USD | 104.4% |
| 2014 Q3 | 1.02 Billion USD | 81.46% |
| 2014 Q2 | 567.25 Million USD | -14.47% |
| 2014 Q1 | 663.19 Million USD | 7.46% |
| 2014 FY | 1.09 Billion USD | 77.64% |
| 2014 Q4 | 1.09 Billion USD | 6.5% |
| 2013 FY | 617.13 Million USD | 30.39% |
| 2013 Q2 | 569.58 Million USD | -0.01% |
| 2013 Q3 | 585.26 Million USD | 2.75% |
| 2013 Q4 | 617.13 Million USD | 5.45% |
| 2013 Q1 | 569.65 Million USD | 20.35% |
| 2012 Q4 | 473.31 Million USD | 59.56% |
| 2012 FY | 473.31 Million USD | 70.59% |
| 2012 Q3 | 296.63 Million USD | -0.65% |
| 2012 Q2 | 298.57 Million USD | -2.91% |
| 2012 Q1 | 307.51 Million USD | 10.83% |
| 2011 Q3 | 138.12 Million USD | 0.0% |
| 2011 Q4 | 277.45 Million USD | 100.88% |
| 2011 FY | 277.45 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Addus HomeCare Corporation | 175.18 Million USD | -762.377% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -1415.761% |
| Amedisys, Inc. | 487.21 Million USD | -210.076% |
| American Oncology Network, Inc. | 128.32 Million USD | -1077.268% |
| Astrana Health, Inc. | 321.01 Million USD | -370.612% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | -0.769% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -1215.153% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -13764.949% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -28582.912% |
| COMPASS Pathways plc | 33.04 Million USD | -4471.041% |
| DocGo Inc. | 46.49 Million USD | -3149.079% |
| The Ensign Group, Inc. | 1.87 Billion USD | 19.268% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -3362.195% |
| InnovAge Holding Corp. | 113.03 Million USD | -1236.514% |
| Assure Holdings Corp. | 14.8 Million USD | -10104.181% |
| The Joint Corp. | 16.73 Million USD | -8927.452% |
| LifeStance Health Group, Inc. | 511.04 Million USD | -195.617% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -229796.992% |
| ModivCare Inc. | 1.14 Billion USD | -32.512% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -454182.175% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -33684.606% |
| Option Care Health, Inc. | 1.16 Billion USD | -29.519% |
| P3 Health Partners Inc. | 124.64 Million USD | -1112.064% |
| P3 Health Partners Inc. | 124.64 Million USD | -1112.064% |
| The Pennant Group, Inc. | 329.63 Million USD | -358.308% |
| Surgery Partners, Inc. | 3.06 Billion USD | 50.656% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -608812.024% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | -1160.885% |
| The Oncology Institute, Inc. | 119.81 Million USD | -1160.885% |